Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. - Wikidata - wikimedia - TriplyDB

Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF.

Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF.

http://www.wikidata.org/entity/Q52601576

about

Platelet gel: a new therapeutic tool with great potential Platelet-rich plasma in orthopedic therapy: a comparative systematic review of clinical and experimental data in equine and human musculoskeletal lesions Biology of platelet-rich plasma and its clinical application in cartilage repair Anti-inflammatory strategies in cartilage repair PRP Treatment Efficacy for Tendinopathy: A Review of Basic Science Studies Role of plasma-rich fibrin in oral surgery Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics Optimisation of a double-centrifugation method for preparation of canine platelet-rich plasma Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors.Platelet-rich plasma application in chondrogenesis Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia Joint pathology and platelet-rich plasma therapies.Platelet rich plasma treatment for chronic Achilles tendinosis.Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis.High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome.HGF mediates the anti-inflammatory effects of PRP on injured tendons.Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk A comparison between platelet-rich plasma (PRP) and hyaluronate acid on the healing of cartilage defects Platelet concentrate in bovine reproduction: effects on in vitro embryo production and after intrauterine administration in repeat breeder cows Improvement of sepsis by hepatocyte growth factor, an anti-inflammatory regulator: emerging insights and therapeutic potential.In vitro effects of platelet-rich gel supernatants on histology and chondrocyte apoptosis scores, hyaluronan release and gene expression of equine cartilage explants challenged with lipopolysaccharide.The role of platelet rich plasma in musculoskeletal science.Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients.Exploratory study for identifying systemic biomarkers that correlate with pain response in patients with intervertebral disc disorders.Adipose-derived mesenchymal stem cells and platelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis in Beagle dogs.Early joint degeneration and antagonism between growth factors and reactive oxygen species. Is non-surgical management possible?White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution.Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and Regeneration.Does platelet-rich plasma enhance the survival of grafted fat? An update review.Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors.Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma.Effects of platelet-rich plasma in a model of bovine endometrial inflammation in vitro Equine tendonitis therapy using mesenchymal stem cells and platelet concentrates: a randomized controlled trial.Platelet rich plasma therapies for sports muscle injuries: any evidence behind clinical practice?Orthopaedic research in italy: state of the art.Platelet-rich plasma and the elimination of neuropathic pain.A biological therapy to osteoarthritis treatment using platelet-rich plasma.Platelet-rich plasma for managing pain and inflammation in osteoarthritis.Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration.

P2860

Q26739936-3BB4C4D3-9679-4ED3-9D79-EC2BA9B3B693 Q26825183-3C186110-E54E-438C-A774-04C9E0B2983D Q26860452-97A57198-87B6-417D-AFA0-8EFEBC83603E Q26862600-87017927-30CE-4169-AFDC-8C4652FE9FA2 Q28070316-F89B6CF1-7895-4B15-A22C-49AF1A343198 Q28070366-6281F5BD-F16A-421F-BFED-A93FEC589252 Q28390520-E1F5B932-47FC-4441-A919-C2A339289AE8 Q33837755-DE932EEA-197B-4ED0-8550-147A557D9EA8 Q33913784-1B58D0C5-C1AC-4E21-B6F8-812A8C4CC295 Q34052680-14A812C1-4823-4F30-98E6-09F49AC7A574 Q34072886-164237F6-0F1D-436C-8B69-4AA2A239EB5B Q34222718-DF67028D-2408-40CB-8D61-F3922F68DB32 Q34240837-77E5410D-AEF5-4BC3-A8B8-6F4541DEA9FF Q34284241-86A967F3-16D7-49B4-BB59-08BD3F398C9C Q34397612-6198129C-676F-4343-B5B4-79AEF36E6E2D Q34625192-02AE824F-8E8C-42A5-A834-F268A71B619F Q34807000-318D536C-BEED-474D-A078-20DF11C01A3B Q34893465-6D674FF6-0E1D-44E4-8A41-B435BE648B8C Q35167075-0D9FE2AD-E386-48EA-ACBC-BB1DDD0F2C36 Q35755240-508B3EA2-1469-4DAC-8D5D-A656204D885F Q35821392-22683E77-7E91-4E17-8AAA-7AC2AC9CD92A Q36066372-19F2C907-0696-4339-8FE6-B15E974BF11A Q36067813-9E89FF0D-F209-42D7-B43F-AA8A8A5619F9 Q36215007-5FB64248-C02F-4326-A197-18B5E04A8EB7 Q36400200-8FEB8B37-DF6B-4B48-8C15-AB46A7732B69 Q36466837-C602A773-53AF-4706-8615-E5AC086DAE90 Q36520020-3DB00A51-CF2D-4786-A82D-DB7E97A5EFA5 Q36564183-D83EB326-9C4F-452D-945B-7129E10328A7 Q36755657-36CDF276-3BA1-425A-9DAF-4D8ACB9AE2AE Q36781644-25A54782-4276-4C56-A304-18B51E2D3A54 Q36997844-5787B07F-1B42-432D-87D3-E03D56DCDDA9 Q37059397-76284316-F4BE-40D1-9981-F76AF9811148 Q37251316-ADF61F52-EFA7-4B7E-9E3C-A7972702D3D9 Q37372264-17CAB5C5-0878-4819-8FB4-5ECA3B2C37C3 Q37833647-181C289B-D943-4B59-A566-304476044C12 Q37888852-43D10481-B628-49CA-8E94-51790498C2E4 Q38119874-19BF6A1E-1FB4-4385-B0BF-E860597392AC Q38120027-1EBAC786-E415-4486-BAEC-747631D40F54 Q38147906-8CA00995-F356-4B0E-9303-8BA402FB50FF Q38166202-C92D5664-46E5-4EE4-BDEA-A25A52ADDD0A

P2860

Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF.

http://www.wikidata.org/entity/Q52601576

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Molecular basis of anti-inflam ...... s of NF-κB inhibition via HGF.

@en

Molecular basis of anti-inflam ...... s of NF-κB inhibition via HGF.

@nl

type

label

Molecular basis of anti-inflam ...... s of NF-κB inhibition via HGF.

@en

Molecular basis of anti-inflam ...... s of NF-κB inhibition via HGF.

@nl

prefLabel

Molecular basis of anti-inflam ...... s of NF-κB inhibition via HGF.

@en

Molecular basis of anti-inflam ...... s of NF-κB inhibition via HGF.

@nl

P1433

Q52601576-05C50868-EDD4-447B-B1A0-9469BD1E8040

P1476

Q52601576-AFDA2F59-375B-467B-974A-4A8DA8789F78

P2093

Q52601576-189C324C-2A83-4DD0-B429-41D990E9ABEE

Q52601576-54E0F1BF-3AB5-4BA3-98B4-183DB7BFD5F6

Q52601576-6A571B94-37C2-4F83-8226-42E8E6B86BDD

Q52601576-A3FB904D-4975-4E03-A08A-52BEE3BCA761

Q52601576-C6A877DE-AF8B-41DA-A0CE-CB5C2325E932

P2860

Q52601576-042C9149-A963-4B30-88CA-A086DE4E7D3E

Q52601576-10C59143-6E4F-4ED3-87D9-920F499C2824

Q52601576-24FE0F65-6A0F-4331-8AA4-0A6D52DF20A0

Q52601576-28166412-2A6A-45B8-8820-DC0E4F5783D7

Q52601576-2CCE50FD-63FC-49C6-A548-A76124957B5D

Q52601576-2E5FE426-AC00-4126-9B28-D13EB5C04B3A

Q52601576-303D0E0F-0E0E-4AB4-B89F-28ECF927BF24

Q52601576-30953EF0-CF9F-4BCC-A768-6DCFC962B89B

Q52601576-311912F5-001E-4AC8-9703-84D319BE3749

Q52601576-4BC5E794-FC90-4996-8BCE-DC718CC5F4D0

P304

Q52601576-CD6E89D5-B440-4815-9886-B3603F8D3593

P31

Q52601576-875640FA-6F92-4477-9875-9581B7BF9F59

P356

Q52601576-2A37DB59-3F6D-4354-832E-A19597F32187

P433

Q52601576-459B5870-6476-4079-BA62-BB6AF7CC10A0

P478

Q52601576-D24C6050-AFB8-4BFF-B8FC-84E082780C2C

P50

Q52601576-3D2AE3E2-20F1-4FF5-8709-40A617A700A1

Q52601576-CAA5830B-8AD5-4BCF-9BDE-952E76D3EA4F

P577

Q52601576-27B39624-28DE-4797-8876-54FA0E9DB8DE

P5875

Q52601576-D269F2F5-9889-4D59-B7AE-A3B68281B1E8

P698

Q52601576-C222ABC9-210F-48F4-9EC4-EC9E2EA0DE29

P921

Q52601576-A8558994-054E-4276-97EC-6A17277E9D38

Q52601576-F91CDA01-1573-4778-AA85-05E391CD088D

P356

P1433

Journal of Cellular Physiology

P1476

Molecular basis of anti-inflam ...... s of NF-κB inhibition via HGF.

@en

P2093

Emanuela Matteucci

http://www.w3.org/2001/XMLSchema#string

Giada Dogliotti

http://www.w3.org/2001/XMLSchema#string

Maria Alfonsina Desiderio

http://www.w3.org/2001/XMLSchema#string

Massimiliano M Corsi

http://www.w3.org/2001/XMLSchema#string

Paola Bendinelli

http://www.w3.org/2001/XMLSchema#string

P2860

A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome

EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line

CCL23 up-regulates expression of KDR/Flk-1 and potentiates VEGF-induced proliferation and migration of human endothelial cells.

Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes: Maintenance of differentiated phenotype under defined culture conditions.

Cytokines and their relationship to the symptoms and outcome of cancer.

Expression profile of human gingival fibroblasts induced by interleukin-1beta reveals central role of nuclear factor-kappa B in stabilizing human gingival fibroblasts during inflammation.

Inflammatory responses in influenza A virus infection.

New regulators of NF-kappaB in inflammation.

Chemokines in joint disease: the key to inflammation?

Hypo-phosphorylation leads to nuclear retention of NF-kappaB p65 due to impaired IkappaBalpha gene synthesis.

P304

757-766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.22274

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

225

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44692547

http://www.w3.org/2001/XMLSchema#string

P698

20568106

http://www.w3.org/2001/XMLSchema#string

P921